United States Ganciclovir Market Report 2017

Publisher Name :
Date: 29-Nov-2017
No. of pages: 103
Inquire Before Buying

In this report, the United States Ganciclovir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Ganciclovir in these regions, from 2012 to 2022 (forecast).

United States Ganciclovir market competition by top manufacturers/players, with Ganciclovir sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Roche

- Bausch & Lomb

- Fresenius Kabi

- Luitpold

- Huatai Pharmaceutical

- Wuhan Hualong Bio-pharmaceutical

- Luoxin

- HUBEI KEYI

- Tungshun Group

- Tiantianming

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Injection

- Oral

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- AIDS

- Tube transplant

- Malignant neoplasms

- CMV Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Ganciclovir Market Report 2017

Table of Contents
United States Ganciclovir Market Report 2017
1 Ganciclovir Overview
1.1 Product Overview and Scope of Ganciclovir
1.2 Classification of Ganciclovir by Product Category
1.2.1 United States Ganciclovir Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Ganciclovir Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Injection
1.2.4 Oral
1.3 United States Ganciclovir Market by Application/End Users
1.3.1 United States Ganciclovir Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 AIDS
1.3.3 Tube transplant
1.3.4 Malignant neoplasms
1.3.5 CMV Infection
1.4 United States Ganciclovir Market by Region
1.4.1 United States Ganciclovir Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Ganciclovir Status and Prospect (2012-2022)
1.4.3 Southwest Ganciclovir Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Ganciclovir Status and Prospect (2012-2022)
1.4.5 New England Ganciclovir Status and Prospect (2012-2022)
1.4.6 The South Ganciclovir Status and Prospect (2012-2022)
1.4.7 The Midwest Ganciclovir Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Ganciclovir (2012-2022)
1.5.1 United States Ganciclovir Sales and Growth Rate (2012-2022)
1.5.2 United States Ganciclovir Revenue and Growth Rate (2012-2022)
2 United States Ganciclovir Market Competition by Players/Suppliers
2.1 United States Ganciclovir Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Ganciclovir Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Ganciclovir Average Price by Players/Suppliers (2012-2017)
2.4 United States Ganciclovir Market Competitive Situation and Trends
2.4.1 United States Ganciclovir Market Concentration Rate
2.4.2 United States Ganciclovir Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Ganciclovir Manufacturing Base Distribution, Sales Area, Product Type
3 United States Ganciclovir Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Ganciclovir Sales and Market Share by Region (2012-2017)
3.2 United States Ganciclovir Revenue and Market Share by Region (2012-2017)
3.3 United States Ganciclovir Price by Region (2012-2017)
4 United States Ganciclovir Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Ganciclovir Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Ganciclovir Revenue and Market Share by Type (2012-2017)
4.3 United States Ganciclovir Price by Type (2012-2017)
4.4 United States Ganciclovir Sales Growth Rate by Type (2012-2017)
5 United States Ganciclovir Sales (Volume) by Application (2012-2017)
5.1 United States Ganciclovir Sales and Market Share by Application (2012-2017)
5.2 United States Ganciclovir Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Ganciclovir Players/Suppliers Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Ganciclovir Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bausch & Lomb
6.2.2 Ganciclovir Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bausch & Lomb Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Fresenius Kabi
6.3.2 Ganciclovir Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Fresenius Kabi Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Luitpold
6.4.2 Ganciclovir Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Luitpold Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Huatai Pharmaceutical
6.5.2 Ganciclovir Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Huatai Pharmaceutical Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Wuhan Hualong Bio-pharmaceutical
6.6.2 Ganciclovir Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Wuhan Hualong Bio-pharmaceutical Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Luoxin
6.7.2 Ganciclovir Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Luoxin Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 HUBEI KEYI
6.8.2 Ganciclovir Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 HUBEI KEYI Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Tungshun Group
6.9.2 Ganciclovir Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Tungshun Group Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Tiantianming
6.10.2 Ganciclovir Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Tiantianming Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Ganciclovir Manufacturing Cost Analysis
7.1 Ganciclovir Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ganciclovir
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Ganciclovir Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ganciclovir Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Ganciclovir Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Ganciclovir Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Ganciclovir Sales Volume Forecast by Type (2017-2022)
11.3 United States Ganciclovir Sales Volume Forecast by Application (2017-2022)
11.4 United States Ganciclovir Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Ganciclovir
Figure United States Ganciclovir Market Size (K Pcs) by Type (2012-2022)
Figure United States Ganciclovir Sales Volume Market Share by Type (Product Category) in 2016
Figure Injection Product Picture
Figure Oral Product Picture
Figure United States Ganciclovir Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Ganciclovir by Application in 2016
Figure AIDS Examples
Table Key Downstream Customer in AIDS
Figure Tube transplant Examples
Table Key Downstream Customer in Tube transplant
Figure Malignant neoplasms Examples
Table Key Downstream Customer in Malignant neoplasms
Figure CMV Infection Examples
Table Key Downstream Customer in CMV Infection
Figure United States Ganciclovir Market Size (Million USD) by Region (2012-2022)
Figure The West Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ganciclovir Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Ganciclovir Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Ganciclovir Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Ganciclovir Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Ganciclovir Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ganciclovir Sales Share by Players/Suppliers
Figure 2017 United States Ganciclovir Sales Share by Players/Suppliers
Figure United States Ganciclovir Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Ganciclovir Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Ganciclovir Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Ganciclovir Revenue Share by Players/Suppliers
Figure 2017 United States Ganciclovir Revenue Share by Players/Suppliers
Table United States Market Ganciclovir Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Ganciclovir Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Ganciclovir Market Share of Top 3 Players/Suppliers
Figure United States Ganciclovir Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Ganciclovir Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Ganciclovir Product Category
Table United States Ganciclovir Sales (K Pcs) by Region (2012-2017)
Table United States Ganciclovir Sales Share by Region (2012-2017)
Figure United States Ganciclovir Sales Share by Region (2012-2017)
Figure United States Ganciclovir Sales Market Share by Region in 2016
Table United States Ganciclovir Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Ganciclovir Revenue Share by Region (2012-2017)
Figure United States Ganciclovir Revenue Market Share by Region (2012-2017)
Figure United States Ganciclovir Revenue Market Share by Region in 2016
Table United States Ganciclovir Price (USD/Pcs) by Region (2012-2017)
Table United States Ganciclovir Sales (K Pcs) by Type (2012-2017)
Table United States Ganciclovir Sales Share by Type (2012-2017)
Figure United States Ganciclovir Sales Share by Type (2012-2017)
Figure United States Ganciclovir Sales Market Share by Type in 2016
Table United States Ganciclovir Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Ganciclovir Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ganciclovir by Type (2012-2017)
Figure Revenue Market Share of Ganciclovir by Type in 2016
Table United States Ganciclovir Price (USD/Pcs) by Types (2012-2017)
Figure United States Ganciclovir Sales Growth Rate by Type (2012-2017)
Table United States Ganciclovir Sales (K Pcs) by Application (2012-2017)
Table United States Ganciclovir Sales Market Share by Application (2012-2017)
Figure United States Ganciclovir Sales Market Share by Application (2012-2017)
Figure United States Ganciclovir Sales Market Share by Application in 2016
Table United States Ganciclovir Sales Growth Rate by Application (2012-2017)
Figure United States Ganciclovir Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Ganciclovir Sales Growth Rate (2012-2017)
Figure Roche Ganciclovir Sales Market Share in United States (2012-2017)
Figure Roche Ganciclovir Revenue Market Share in United States (2012-2017)
Table Bausch & Lomb Basic Information List
Table Bausch & Lomb Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bausch & Lomb Ganciclovir Sales Growth Rate (2012-2017)
Figure Bausch & Lomb Ganciclovir Sales Market Share in United States (2012-2017)
Figure Bausch & Lomb Ganciclovir Revenue Market Share in United States (2012-2017)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Fresenius Kabi Ganciclovir Sales Growth Rate (2012-2017)
Figure Fresenius Kabi Ganciclovir Sales Market Share in United States (2012-2017)
Figure Fresenius Kabi Ganciclovir Revenue Market Share in United States (2012-2017)
Table Luitpold Basic Information List
Table Luitpold Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Luitpold Ganciclovir Sales Growth Rate (2012-2017)
Figure Luitpold Ganciclovir Sales Market Share in United States (2012-2017)
Figure Luitpold Ganciclovir Revenue Market Share in United States (2012-2017)
Table Huatai Pharmaceutical Basic Information List
Table Huatai Pharmaceutical Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Huatai Pharmaceutical Ganciclovir Sales Growth Rate (2012-2017)
Figure Huatai Pharmaceutical Ganciclovir Sales Market Share in United States (2012-2017)
Figure Huatai Pharmaceutical Ganciclovir Revenue Market Share in United States (2012-2017)
Table Wuhan Hualong Bio-pharmaceutical Basic Information List
Table Wuhan Hualong Bio-pharmaceutical Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wuhan Hualong Bio-pharmaceutical Ganciclovir Sales Growth Rate (2012-2017)
Figure Wuhan Hualong Bio-pharmaceutical Ganciclovir Sales Market Share in United States (2012-2017)
Figure Wuhan Hualong Bio-pharmaceutical Ganciclovir Revenue Market Share in United States (2012-2017)
Table Luoxin Basic Information List
Table Luoxin Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Luoxin Ganciclovir Sales Growth Rate (2012-2017)
Figure Luoxin Ganciclovir Sales Market Share in United States (2012-2017)
Figure Luoxin Ganciclovir Revenue Market Share in United States (2012-2017)
Table HUBEI KEYI Basic Information List
Table HUBEI KEYI Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure HUBEI KEYI Ganciclovir Sales Growth Rate (2012-2017)
Figure HUBEI KEYI Ganciclovir Sales Market Share in United States (2012-2017)
Figure HUBEI KEYI Ganciclovir Revenue Market Share in United States (2012-2017)
Table Tungshun Group Basic Information List
Table Tungshun Group Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tungshun Group Ganciclovir Sales Growth Rate (2012-2017)
Figure Tungshun Group Ganciclovir Sales Market Share in United States (2012-2017)
Figure Tungshun Group Ganciclovir Revenue Market Share in United States (2012-2017)
Table Tiantianming Basic Information List
Table Tiantianming Ganciclovir Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tiantianming Ganciclovir Sales Growth Rate (2012-2017)
Figure Tiantianming Ganciclovir Sales Market Share in United States (2012-2017)
Figure Tiantianming Ganciclovir Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ganciclovir
Figure Manufacturing Process Analysis of Ganciclovir
Figure Ganciclovir Industrial Chain Analysis
Table Raw Materials Sources of Ganciclovir Major Players/Suppliers in 2016
Table Major Buyers of Ganciclovir
Table Distributors/Traders List
Figure United States Ganciclovir Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Ganciclovir Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Ganciclovir Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Ganciclovir Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ganciclovir Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Ganciclovir Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Ganciclovir Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ganciclovir Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Ganciclovir Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Ganciclovir Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Ganciclovir Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ganciclovir Sales Volume Share Forecast by Region (2017-2022)
Figure United States Ganciclovir Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 24
    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2018, provides an overview of the Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline landscape. Elephantiasis commonly known as Lymphatic filariasis occurs when filarial parasites are transmitted to humans through mosquitoes. Infe......
  • Lyme Disease - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 41
    Lyme Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lyme Disease - Pipeline Review, H2 2018, provides an overview of the Lyme Disease (Infectious Disease) pipeline landscape. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factor......
  • Smallpox - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 73
    Smallpox - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Pipeline Review, H2 2018, provides an overview of the Smallpox (Infectious Disease) pipeline landscape. Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, prostration, severe back pain, abdominal pain and vomiting. This is followed by the development of rashe......
  • Warts - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 100
    Warts - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Pipeline Review, H2 2018, provides an overview of the Warts (Infectious Disease) pipeline landscape. Warts are skin growth that is caused by virus called human papillomavirus (HPV). HPV infects the top layer of skin, usually entering the body in an area of broken skin. The virus causes the top layer of skin to grow rapidly, fo......
  • Bacterial Vaginosis - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 62
    Bacterial Vaginosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Vaginosis - Pipeline Review, H2 2018, provides an overview of the Bacterial Vaginosis (Infectious Disease) pipeline landscape. Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burni......
  • Streptococcus pyogenes Infections - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 36
    Streptococcus pyogenes Infections - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes Infections - Pipeline Review, H2 2018, provides an overview of the Streptococcus pyogenes Infections (Infectious Disease) pipeline landscape. Streptococcus pyogenes infections are caused by Streptococcus pyogenes, a spherical, Gram-positive bacterium. Symptoms include significant pain......
  • Cholera - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 50
    Cholera - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Pipeline Review, H2 2018, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Cholera is an acute infectious disease caused by a bacterium, Vibrio cholera, which results in a painless, watery diarrhea in humans. Symptoms of cholera can begin as soon as a few hours or as long as five days after infe......
  • Plague - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 75
    Plague - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plague - Pipeline Review, H2 2018, provides an overview of the Plague (Infectious Disease) pipeline landscape. Plague is an infection caused by the bacterium Yersinia pestis. The organism is transmitted to humans who are bitten by fleas that have fed on infected rodents or by humans handling infected animals. Symptoms include headach......
  • Botulism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Botulism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Pipeline Review, H2 2018, provides an overview of the Botulism (Infectious Disease) pipeline landscape. Botulism is a rare but serious illness. The cause is a toxin (poison) made by a bacterium called Clostridium botulinum. It occurs naturally in soil. Food borne botulism comes from eating foods contaminated with the tox......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs